GenScript ProBio Congratulates Eutilex’s IND Clearance from MFDS
NANJING, China, March 7, 2023 /PRNewswire/ -- Recently, Eutilex, a partner of GenScript ProBio, announced MFDS (Ministry of Food and Drug Safety) clearance of its hepatocellular carcinoma clinical trial application for innovative CAR-T program (EU307). GenScript ProBio extends congratulations on this. 2 years ago, GenScript ProBio and Eutilex announced that the parties entered...
Appian and Roboyo Help Primary Health Tasmania Achieve Better Community Health and Wellbeing Outcomes
SYDNEY, March 7, 2023 /PRNewswire/ -- Appian (Nasdaq: APPN) and its partner Roboyo announced today that the two companies are working with Primary Health Tasmania to improve health service commissioning through process automation. Primary Health Tasmania, a non-government, not-for-profit organisation, is one of 31 similar organisations established under the Australian Government's Primary Health...
SiYi Intelligence Raises Nearly $15 Million in Series A Financing
SHANGHAI, March 6, 2023 /PRNewswire/ -- SiYi Intelligence, an intelligent rehabilitation solution provider, completed nearly 15 million US dollars in Series A financing. This round was led by Chengdu Bio-town Equity Investment Fund with participation from existing investor Tao Capital. The company plans to use the funding to accelerate the R&D of integration solutions for neurorehabilitation and build the digital...
AnPac Bio-Medical Science Announces US$5 Million Private Placement
NEW YORK, March 6, 2023 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. (Nasdaq: ANPC) ("AnPac Bio," the "Company" or "we"), a company with operations in the United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commerce food platform focused on the sale of Asian sourced food...
Hummingbird Bioscience Exercises Its Option to License the Clinical Trial Results from Cancer Research UK to Support Further Development of HMBD-001
SINGAPORE and LONDON, March 6, 2023 /PRNewswire/ -- Hummingbird Bioscience, a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat diseases, and Cancer Research Horizons, the innovation arm of Cancer Research UK (CRUK), today announced that Hummingbird Bioscience has exercised its option to license in the first-in-human (FIH) clinical...
HanAll Biopharma’s Licensed Partner in China Announces Positive Topline Phase 3 Results for Batoclimab in Myasthenia Gravis
The trial met its primary endpoint and key secondary endpoints, with a favorable safety profile Batoclimab is one of the most advanced FcRn inhibitors being developed in Greater China for the treatment of myasthenia gravis SEOUL, South Korea, March 6, 2023 /PRNewswire/ -- HanAll Biopharma Co., Ltd. (KRX: 009420. KS)...
Assure Tech Launches a New Platform – Comprehensive Health Solution
HANGZHOU, China, March 6, 2023 /PRNewswire/ -- With the rapid development of the social economy and the continuous improvement in people's living standard, pets, especially cats and dogs, have gradually become important family members in modern times. World wide, strong demand for pet-related products and healthcare services has given rise to a US$100 billion industrial chain in pet economy....
Harbour BioMed Announces Positive Topline Results from Phase III Trial of Batoclimab for Treatment of Generalized Myasthenia Gravis
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, March 6, 2023 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunology, announces the positive topline results of its phase III clinical trial of batoclimab (HBM9161) for...
Confirmatory clinical trial of Liwen RF™ ablation system in China concluded
HANGZHOU, China, March 6, 2023 /PRNewswire/ -- On March 3, Venus Medtech (Hangzhou) Inc. (Venus Medtech, 2500.HK), trailblazer in structural heart therapies worldwide, announced that the Liwen RF™ ablation system developed by the Company has successfully enrolled one patient at West China Hospital, Sichuan University, thus completing the enrollment of patients for confirmatory clinical trial in China. This...
US proteomics sector set for shake-up as new IonOpticks tech unveiled
IonOpticks to introduce the TS, a fully integrated column heating and interface solution for Thermo Scientific users MELBOURNE, Australia, March 3, 2023 /PRNewswire/ -- IonOpticks, a producer of high-performance chromatography solutions for the global research community, will introduce the new TS product range to the US market at US HUPO's (US Human Proteome Organization) 19th Annual Conference in...
